Health Tech Coverage - MedCity News
This week at HLTH, FDA Commissioner Robert Califf discussed the current state of healthcare AI. He talked about some of the qualms he has, such as his worry that AI is worsening health inequities ...
Katie Adams, Author at MedCity News
Katie Adams. Katie Adams is a senior reporter for MedCity News covering providers and healthcare technology. Previously, she worked as a healthcare technology editor at Becker’s Hospital Review ...
MedCity News, Author at MedCity News
A 3-part checklist that gets you ready for the value-based world of healthcare. The writing has been on the wall for years: the shift away from fee for service to value-based pay is coming ...
Clinical Trials - MedCity News
The FDA had asked Biogen and Sage Therapeutics to provide more clinical data supporting Zurzuvae in major depressive disorder. Citing the time and expense of additional clinical trials, the ...
Paul Bresge Coverage - MedCity News
Ray Therapeutics’ gene therapy is independent of the causative genes driving inherited vision disorders, which CEO Paul Bresge says is important for reaching a broad patient population. Rare ...
MedCity FemFwd: Why Employed Women Have Higher Out-of …
Dec 17, 2023 · In this episode, we’re joined by Marielle Farina, senior manager of Deloitte. Farina recently co-authored a report that found that employed women have $15.4 billion more in out-of-pocket ...
Safe and Affordable Family-Forming Benefits Provide a …
Feb 16, 2024 · Contemporary households reflect the evolving tapestry of society, embracing the diversity of same-sex partnerships, single parenthood, and professional women choosing to embark on parenthood later ...
Viking Therapeutics Coverage - MedCity News
Higher doses of a Viking Therapeutics pill that targets two receptors led to greater weight loss without worsening safety or tolerability, according to Phase 1 results presented during the ...
Translarna Coverage - MedCity News
European Commission Decision Is a Reprieve for PTC Therapeutics’ Rare Muscle Disease Drug The PTC Therapeutics drug Translarna failed its confirmatory study in Duchenne muscular dystrophy.
Roivant extends AI drug discovery reach with $450M Silicon …
Feb 26, 2021 · New York and Basel, Switzerland-based Roivant is acquiring Silicon Therapeutics, a computational drug discovery startup that has advanced from company launch to clinical testing in four years ...
- Some results have been removed